Lagos, Nigeria – 1st April 2026
MeCure Industries PLC, a leading pharmaceutical manufacturer in Nigeria, is pleased to announce the successful and full redemption of its ₦3 billion Senior Secured Bond (Series 1) issued under its ₦20 billion Debt Issuance Programme.
The bond, originally issued on 14th May 2021, marked the company’s debut transaction in the Nigerian capital market. The full repayment underscores MeCure’s strong financial discipline, robust cash flow management, and commitment to meeting its obligations to investors.
Speaking on the milestone, the Chief Financial Officer of MeCure Industries PLC commented:
“The successful redemption of our Series 1 bond is a significant achievement for MeCure. It reflects not only our financial resilience but also the confidence that the capital markets placed in us during our debut issuance. We are proud to have honored this obligation in full and on schedule.”
He further added:
“The company delivered a solid performance in 2025, driven by operational efficiency, expanded market reach, and continued investment in manufacturing capabilities. As we look ahead, we are optimistic about 2026, with a strong pipeline of opportunities that will support sustainable growth and long-term value creation.”
Since its issuance, the bond has played a key role in supporting MeCure’s strategic initiatives, including capacity expansion, product development, and strengthening its distribution network across Nigeria and export markets.
This milestone reinforces MeCure’s position as a credible and disciplined issuer in the Nigerian capital market, setting a strong foundation for future engagements with investors as the company continues to pursue its growth ambitions.
